It reduces muscle mass loss during weight loss in frail older adults with obesity [6] and also improves insulin sensitivity of the muscles in older adults with obesity and type 2 diabetes [7]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.